RB1 Loss as a Diagnostic Clue in a High‐Grade Glioma With Pleomorphic and Pseudopapillary Features (HPAP): The First Reported Case With Spinal Metastasis and a Review of the Literature
- 21 July 2026
- journal article
- review article
- Published by Wiley in Pathology International
- Vol. 76 (7) , e70150
Abstract
High‐grade glioma with pleomorphic and pseudopapillary features (HPAP) is a recently described entity defined by a distinct DNA methylation signature, recurrent monosomy 13, and mutations in TP53, RB1, and NF1. Most cases are supratentorial with a relatively favorable prognosis. We report a 45‐year‐old woman who presented with a right cerebellar mass exhibiting striking histopathological heterogeneity comprising low‐grade and high‐grade components. The high‐grade component demonstrated a p53 null immunophenotype and complete loss of RB1 expression, contrasting with wild‐type staining in the low‐grade areas. Molecular analysis confirmed pathogenic variants in TP53 (p.Pro27LeufsTer17), NF1, and NF2, with losses of chromosomes 13 and 17. Despite gross total resection and adjuvant chemoradiotherapy, the patient developed spinal intradural metastasis 26 months postoperatively. The metastatic lesion mirrored the high‐grade primary component immunohistochemically and harbored a newly acquired TERT promoter mutation. DNA methylation profiling of the spinal metastasis classified the tumor as HPAP. This case represents the first documented spinal metastasis and the first p53 null phenotype in HPAP, suggesting a potential role for combined RB1 and p53 immunohistochemistry in the diagnostic workup and highlighting the capacity for neuraxis dissemination in this emerging entity.Keywords
This publication has 6 references indexed in Scilit:
- BRAF -mutant high-grade glioma with pleomorphic and pseudopapillary features (HPAP): A PLNTY mimic demonstrating tumor progression during longitudinal follow-upNeuro-Oncology Advances, 2026
- Expanding clinicopathologic knowledge in high-grade glioma with pleomorphic and pseudopapillary features (HPAP): a report of two casesActa Neuropathologica Communications, 2025
- KS04.6.A GLIOMAS WITH PLEOMORPHIC AND PSEUDOPAPILLARY FEATURES (GPAP) ARE CIRCUMSCRIBED TUMORS WITH LONG-TERM SURVIVALNeuro-Oncology, 2024
- An incidental finding of a high-grade glioma with pleomorphic and pseudopapillary features (HPAP) with PBRM1 mutationJournal of Neuropathology & Experimental Neurology, 2024
- High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13Acta Neuropathologica, 2022
- Alterations in the RB Pathway With Inactivation of RB1 Characterize Glioblastomas With a Primitive Neuronal ComponentJournal of Neuropathology & Experimental Neurology, 2021